Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint
(Q30620954)
scientific article
scientific article
Language:
Current Data About
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint